From here:
With an epidemic of Type 2 diabetes creating huge concerns in the healthcare community, and providing big treatment opportunities, drugmakers are bringing on new treatments for the condition or looking for studies that support the use of the drugs they already make. And the American Diabetes Association meeting, which began over the weekend in Philadelphia, is where those studies get released and talked about. Here are some of those with the most interest.
Well, the strategy is simple: why to produce new medicines? It is more efficient just to convince society that already existed products are perfect!
No comments:
Post a Comment